NIH-funded research R01 grant

Understanding how sleep patterns affect cravings for fentanyl

Official title: Novel roles for the circadian transcription factor NPAS2 and striatal dopamine D3 receptor signaling in diurnal fentanyl craving and relapse

Funded at Univ of Massachusetts Med Sch Worcester · NIH-11133020 · Data updated 2026-11-12

This study is looking at how sleep problems might make people with opioid use disorder crave fentanyl more, and it’s exploring a protein that helps control our sleep-wake cycles to see how it affects brain signals related to cravings, with the hope of finding ways to improve sleep and reduce those cravings.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startJuly 15, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$466,181
NIH project number5R01DA061243-02
Project IDNIH-11133020 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with opioid use disorder who experience significant sleep disturbances.

Less likely to help

Patients who do not have opioid use disorder or those without sleep-related issues may not benefit from this research.

What this research studies

This research investigates the relationship between sleep disturbances and cravings for fentanyl in individuals with opioid use disorder. It focuses on the role of a specific protein, NPAS2, which is involved in regulating circadian rhythms and how it affects dopamine signaling in the brain. By studying these mechanisms, the research aims to uncover how disruptions in sleep can lead to increased cravings and relapse into opioid use. The findings could help develop targeted interventions to improve sleep and reduce cravings.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help manage cravings and reduce relapse rates in individuals recovering from opioid addiction.

How similar studies have gone: Previous research has shown promising results in understanding the link between circadian rhythms and substance use disorders, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Logan, Ryan W — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Logan, Ryan W

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.